Evolution of clinical practice guidelines: Evidence supporting expanded use of medicines

Disease Management

Volumn 9, Issue 4, 2006, Pages 210-223

  Dubois, Robert W ^a   Dean, Bonnie B ^a  

^a CERNER CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL FEATURE; CLINICAL PRACTICE; DRUG UTILIZATION; ECONOMIC ASPECT; EVIDENCE BASED MEDICINE; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; HUMAN; INTERNET; LONG TERM CARE; MEDICAL CARE; MEDICAL INFORMATION; MEDLINE; MONOTHERAPY; ORGANIZATION; POLICY; POLYPHARMACY; PRACTICE GUIDELINE; RISK FACTOR; UNITED STATES;

ASTHMA; DEPRESSIVE DISORDER; DIABETES MELLITUS; DISEASE MANAGEMENT; DRUG COSTS; HEART FAILURE, CONGESTIVE; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; PHARMACEUTICAL PREPARATIONS; PRACTICE GUIDELINES; UNITED STATES;

EID: 33751313566     PISSN: 1093507X     EISSN: None     Source Type: Journal    
DOI: 10.1089/dis.2006.9.210     Document Type: Article

References (63)

1. Centers for Medicare & Medicaid Services. National health expenditures. Available at: www.cms.hhs.gov. Accessed January 10, 2005.
2. Dubois RW, Batchlor E, Wade S. Geographic variation in the use of medications: is uniformity good news or bad? Health Aff (Millwood) 2002;21:240-250.
3. Gilberg K, Laouri M, Wade S, Isonaka S. Analysis of medication use patterns: apparent overuse of antibiotics and underuse of prescription drugs for asthma, depression, and CHF. J Manag Care Pharm 2003;9:232-237.
4. Peterson ED, Pollack CV Jr, Roe MT, et al. Early use of glycoprotein IIb/IIIa inhibitors in non-ST-elevation acute myocardial infarction: observations from the National Registry of Myocardial Infarction 4. J Am Coll Cardiol 2003;42:45-53.
5. Butler J, Arbogast PG, Daugherty J, et al. Outpatient utilization of angiotensin-converting enzyme inhibitors among heart failure patients after hospital discharge. J Am Coll Cardiol 2004;43:2036-2043.
6. Rosen AB, Karter AJ, Liu JY, Selby JV, Schneider EC. Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in high-risk clinical and ethnic groups with diabetes. J Gen Intern Med 2004;19:669-675.
7. Brown AF, Gross AG, Gutierrez PR, et al. Income-related differences in the use of evidence-based therapies in older persons with diabetes mellitus in for-profit managed care. J Am Geriatr Soc 2003;51:665-670.
8. Timpe EM, Amarshi N, Reed PJ. Evaluation of angiotensin-converting enzyme inhibitor use in patients with type 2 diabetes in a state managed care plan. Am J Manag Care 2004;10:124-129.
9. Gupta K, Gupta S. Undertreatment of hypertension: a dozen reasons. Arch Intern Med 2002;162:2246-2247.
10. McGlynn EA, Asch SM, Adams J, et al. The quality of health care delivered to adults in the United States. N Engl J Med 2003;348:2635-2645.
11. Kleinke JD. Access versus excess: value-based cost sharing for prescription drugs. Health Aff (Millwood) 2004;23:34-47.
12. L2. Park RE, Fink A, Brook RH, et al. Physician ratings of appropriate indications for six medical and surgical procedures. Am J Public Health 1986;76:766-772.
13. Board on Health Care Services (HCS), Institute of Medicine (IOM). Priority areas for national action: transforming health care quality. Washington, DC: National Academy of Sciences, 2003.
14. American Academy of Allergy, Asthma & Immunology. Facts about allergic asthma. Available at: www.aaaai.org/patients/allergic_asthma/facts.stm. Accessed July 7, 2006.
15. American Heart Association. Heart disease and stroke statistics-2004 update. Dallas, TX: American Heart Association, 2003.
16. National Institute of Mental Health. Fact sheet. Available at: www.nimh.nih.gov/healthinformation/depressionmenu.cfm. Accessed July 7, 2006.
17. Centers for Disease Control and Prevention. National diabetes fact sheet. Available at: www.cdc.gov/diabetes/pubs/estimates.htm#prev. Accessed July 7, 2006.
18. National Heart, Lung, and Blood Institute. Congestive heart failure in the United States: a new epidemic (data fact sheet). Data compiled from the National Health and Nutrition Examination Survey (1976-80 and 1988-91), Center for Health Statistics. Available at: www.nhlbi.nih.gov/health/public/heart/ other/CHF.htm. Accessed July 7, 2006.
19. National Institute of Health. Press release: NHLBI study finds hostility, impatience increase hypertension risk. Available at: www.nhlbi.nih.gov/new/ press/03-10-21.htm. Accessed July 7, 2006.
20. American Thoracic Society Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986. Am Rev Respir Dis 1987;136:225-244.
21. Harrison's principles of internal medicine, 8th ed. New York: McGraw-Hill, 1977.
22. Harrison's principles of internal medicine, 9th ed. New York: McGraw-Hill, 1980.
23. National Heart, Lung, and Blood Institute. National asthma education and prevention program. Expert panel report: guidelines for the diagnosis and management of asthma. Bethesda, MD: National Institutes of Health, 1991.
24. National Heart, Lung, and Blood Institute. National asthma education and prevention program. Expert panel report 2: guidelines for the diagnosis and management of asthma. Bethesda, MD: National Institutes of Health, 1997.
25. National Heart, Lung, and Blood Institute. National asthma education and prevention program. Update 2002. Expert panel report: guidelines for the diagnosis and management of asthma. Bethesda, MD: National Institutes of Health, 2002.
26. Cecil-Loeb textbook of medicine, 13th ed. Philadelphia: Saunders, 1971.
27. Cecil textbook of medicine, 17th ed. Philadelphia: Saunders, 1985.
28. Harrison's principles of internal medicine, 7th ed. New York: McGraw-Hill, 1974.
29. Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. Arch Intern Med 1988;148:36-69.
30. Summary of the second report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II). JAMA 1993;269:3015-3023.
31. Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. A cooperative study. JAMA 1977;237:255-261.
32. The 1980 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1980;140:1280-1285.
33. The 1984 Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1984;144:1045-1057.
34. Fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V). Arch Intern Med 1993;153:154-183.
35. Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003;289:2560-2572.
36. Diabetes Guidelines Task Force. AACE guidelines for the treatment of diabetes mellitus-1994 update. Endocrine Practice 1995;1:149-157.
37. American Association of Clinical Endocrinologists and the American College of Endocrinology. The American Association of Clinical Endocrinologists medical guidelines for the management of diabetes mellitus: the AACE system of intensive diabetes self-management-2000 update. Endocrine Practice 2000;6:43-84.
38. American Association of Clinical Endocrinologists and the American College of Endocrinology. The American Association of Clinical Endocrinologists medical guidelines for the management of diabetes mellitus: The AACE system of intensive diabetes self-management-2002 update. Endocrine Practice 2002;8:40-82.
39. The 1988 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1988;148:1023-1038.
40. National Diabetes Education Program guiding principles for diabetes care for health care providers and people with diabetes. Available at: www.stanford.edu/group/usvk/stanford/misc/Diabetes%202.pdf. Accessed July 7, 2006.
41. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497.
42. Merck manual of diagnosis and therapy. Available at: www.merck.com/ mrkshared/mmanual/sections.jsp. Accessed June 1, 2006.
43. Cecil textbook of medicine, 18th ed. Philadelphia: Saunders, 1988.
44. Cecil textbook of medicine, 19th ed. Philadelphia: Saunders, 1992.
45. Harrison's principles of internal medicine, 12th ed. New York: McGraw-Hill, 1991.
46. Hunt SA, Baker DW, Chin MH, et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol 2001;38:2101-2113.
47. Cecil textbook of medicine, 20th ed. Philadelphia: Saunders, 1996.
48. Harrison's principles of internal medicine, 15th ed. New York: McGraw-Hill, 2001.
49. Guidelines for the evaluation and management of heart failure. Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Evaluation and Management of Heart Failure). Circulation 1995;92:2764-2784.
50. Mood disorders: pharmacologic prevention of recurrences. National Institutes of Health Consensus Development Conference Statement. Natl Inst Health Consens Dev Conf Consens Statement 1984;5:8.
51. American Psychiatric Association. Practice guideline for major depressive disorder in adults. Am J Psychiatry 1993;150:1-26.
52. American Psychiatric Association. Practice guideline for the treatment of patients with major depressive disorder (revision). Am J Psychiatry 2000;157:1-45.
53. Agency for Healthcare Research and Quality (AHRQ). Depression in primary care. Vol. 2: Treatment of major depression (Clinical practice guideline no. 5; AHRQ publication no. 93-0551). Washington, DC: AHRQ, 1993.
54. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002;360:1903-1913.
55. Grundy SM, Cleeman JI, Merz CN, et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 2004;110:227-239.
56. Sever PS, Dahlof B, Poulter NR, et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet 2003;361:1149-1158.
57. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2005;28(Suppl 1):S4-S36.
58. Yeh ET. CRP as a mediator of disease. Circulation 2004;109:II11-II14.
59. National Institutes of Health (NIH). Lowering blood cholesterol to prevent heart disease. NIH consensus development conference statement. Arteriosclerosis 1985;5:404-412.
60. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care 1989;12:365-368.
61. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care 1994;17:616-623.
62. American Diabetes Association. Clinical practice recommendations 2002. Diabetes Care 2002;25:S1-S147.
63. Sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997;157:2413-2446.